Viridian Therapeutics (VRDN) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free VRDN Stock Alerts $14.63 +0.36 (+2.52%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Viridian Therapeutics Stock Price Performance5 Day Performance+5.25%1 Month Performance-2.98%3 Month Performance-21.30%6 Month Performance-7.87%Year-To-Date Performance-32.83%1 Year Performance-36.14% Receive VRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. VRDN Stock Chart for Friday, May, 17, 2024 VRDN Chart by TradingView Viridian Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$14.27$14.63+2.52%$14.79$13.95807,829 shs$933.72 million05/15/2024$14.67$14.27-2.73%$15.43$14.20719,138 shs$910.71 million05/14/2024$14.34$14.67+2.30%$15.05$14.35640,880 shs$936.24 million05/13/2024$13.90$14.34+3.17%$14.71$13.93624,071 shs$915.18 million05/10/2024$13.91$13.90-0.07%$14.05$13.34858,045 shs$887.10 million05/09/2024$14.90$13.91-6.64%$14.34$13.501.73 million shs$887.74 million Get the Latest News and Ratings for VRDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$15.14$14.90-1.59%$15.71$14.411.01 million shs$950.92 million05/07/2024$15.59$15.14-2.89%$15.76$14.91643,558 shs$966.24 million05/06/2024$15.40$15.59+1.23%$15.70$15.18568,497 shs$994.99 million05/03/2024$14.58$15.40+5.62%$15.50$15.03757,482 shs$982.83 million05/02/2024$13.81$14.58+5.58%$14.63$13.95854,378 shs$930.50 million05/01/2024$13.26$13.81+4.15%$14.40$13.311.02 million shs$881.38 million04/30/2024$13.60$13.26-2.50%$13.79$13.20898,244 shs$832.33 million04/29/2024$12.88$13.60+5.59%$13.63$12.581.07 million shs$853.67 million04/26/2024$12.70$12.88+1.42%$13.06$12.43538,173 shs$808.48 million04/25/2024$13.03$12.70-2.53%$12.96$12.20958,718 shs$797.18 million04/24/2024$14.25$13.03-8.56%$14.68$12.99771,184 shs$817.89 million04/23/2024$14.30$14.25-0.35%$15.01$14.23538,426 shs$894.47 million04/22/2024$14.60$14.30-2.05%$14.74$14.00812,430 shs$897.58 million04/19/2024$15.16$14.60-3.69%$15.51$14.401.49 million shs$916.44 million04/18/2024$15.08$15.16+0.53%$15.75$14.93580,684 shs$951.59 million04/17/2024$15.09$15.08-0.07%$15.26$14.85661,453 shs$946.54 million04/16/2024$15.64$15.09-3.52%$15.54$15.02679,981 shs$947.20 million04/15/2024$15.89$15.64-1.57%$15.95$15.20881,392 shs$981.72 million04/12/2024$16.21$15.89-1.97%$16.32$15.67773,617 shs$997.42 million04/11/2024$16.11$16.21+0.62%$16.47$15.95587,257 shs$1.02 billion04/10/2024$16.85$16.11-4.39%$16.37$15.53955,428 shs$1.01 billion04/09/2024$16.90$16.85-0.30%$17.32$16.53553,388 shs$1.06 billion04/08/2024$16.32$16.90+3.55%$17.10$16.28530,433 shs$1.06 billion04/05/2024$16.32$16.32$16.62$15.71493,963 shs$1.02 billion04/04/2024$16.26$16.32+0.37%$16.85$16.121.01 million shs$1.02 billion04/03/2024$16.69$16.26-2.58%$16.80$16.17586,933 shs$1.02 billion04/02/2024$17.26$16.69-3.30%$16.90$16.42913,384 shs$1.05 billion04/01/2024$17.51$17.26-1.43%$17.69$16.89608,789 shs$1.08 billion03/29/2024$17.51$17.51$17.93$17.211.01 million shs$1.10 billion03/28/2024$17.51$17.51$17.86$17.211.01 million shs$1.10 billion03/27/2024$17.37$17.51+0.81%$18.02$17.14707,704 shs$1.10 billion03/26/2024$17.55$17.37-1.03%$17.87$17.25621,252 shs$1.09 billion03/25/2024$18.01$17.55-2.55%$18.33$17.30921,860 shs$1.10 billion03/22/2024$18.78$18.01-4.10%$18.94$17.85849,847 shs$1.13 billionObama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here03/21/2024$18.10$18.78+3.76%$19.07$17.921.41 million shs$1.18 billion03/20/2024$17.21$18.10+5.17%$18.16$17.231.08 million shs$1.14 billion03/19/2024$17.34$17.21-0.75%$18.01$17.181.13 million shs$1.08 billion03/18/2024$17.09$17.34+1.46%$17.62$16.161.54 million shs$1.09 billion03/15/2024$17.25$17.09-0.93%$17.73$16.903.85 million shs$1.07 billion03/14/2024$17.81$17.25-3.14%$17.76$16.80977,750 shs$1.08 billion03/13/2024$17.60$17.81+1.19%$17.96$17.26778,016 shs$1.12 billion03/12/2024$19.69$17.60-10.61%$19.65$17.55895,575 shs$1.10 billion03/11/2024$19.14$19.69+2.87%$20.21$19.201.07 million shs$1.24 billion03/08/2024$19.36$19.14-1.14%$20.03$18.94527,449 shs$1.20 billion03/07/2024$18.57$19.36+4.25%$19.37$18.40857,548 shs$1.22 billion03/06/2024$18.11$18.57+2.54%$18.96$18.05914,917 shs$1.17 billion03/05/2024$19.05$18.11-4.93%$19.21$17.92625,720 shs$1.14 billion03/04/2024$19.89$19.05-4.22%$20.50$18.98812,732 shs$1.20 billion03/01/2024$18.71$19.89+6.31%$20.24$18.881.48 million shs$1.25 billion02/29/2024$20.17$18.71-7.24%$20.95$18.561.14 million shs$983.88 million02/28/2024$19.61$20.17+2.86%$21.46$18.671.90 million shs$1.06 billion02/27/2024$19.27$19.61+1.76%$19.98$18.60776,164 shs$1.03 billion02/26/2024$18.77$19.27+2.66%$19.75$18.51588,196 shs$1.01 billion02/23/2024$17.99$18.77+4.34%$19.12$17.64596,979 shs$987.11 million02/22/2024$18.52$17.99-2.86%$18.82$17.97531,777 shs$946.09 million02/21/2024$19.23$18.52-3.69%$19.46$18.18626,834 shs$973.97 million02/20/2024$18.59$19.23+3.44%$19.26$18.14794,466 shs$1.01 billion02/19/2024$18.59$18.59$19.24$18.49897,100 shs$977.57 million02/16/2024$19.23$18.59-3.33%$19.24$18.49897,173 shs$977.65 million Related Companies: CDNA Stock Chart FLGT Stock Chart CSTL Stock Chart CELC Stock Chart SERA Stock Chart VCYT Stock Chart PMD Stock Chart FTRE Stock Chart ARWR Stock Chart GH Stock Chart Receive VRDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRDN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe 1,000X Crypto PlaybookTrue Market InsidersWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.